Showing 61-70 of 160 results for "".
- 10xBio Completes Enrollment of Phase 2b Trial of Novel Drug for Submental Body Contouringhttps://modernaesthetics.com/news/10xbio-completes-enrollment-of-phase-2b-trial-of-novel-drug-for-submental-body-contouring/2473477/10xBio completed enrollment in a repeat treatment study of its novel injectable drug for submental body contouring. The drug, 10
- Body Contouring Doesn't Increase Long-term Weight Loss after Bariatric Surgery: Studyhttps://modernaesthetics.com/news/body-contouring-doesnt-increase-long-term-weight-loss-after-bariatric-surgery-study/2473421/For patients who experience massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated with long-term weight loss, reports a
- FDA Clears Renuvion APR Handpiece for Coagulation of Subcutaneous Soft Tissues after Liposuction for Body Contouringhttps://modernaesthetics.com/news/fda-clears-renuvion-apr-handpiece-for-coagulation-of-subcutaneous-soft-tissues-after-liposuction-for-body-contouring/2473404/The U.S. Food and Drug Administration (FDA) cleared the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring. “The Renuvion APR handpiece is the only device to have a 510(k)
- EON Robotic Body Contouring Device Gains Additional FDA Clearance for Back and Thighshttps://modernaesthetics.com/news/eon-robotic-body-contouring-device-gains-additional-fda-clearance-for-back-and-thighs/2473380/EON Smarter Body Contouring has received FDA clearance for the back and thighs—the third FDA clearance for EON. The device was previously FDA-cleared for clinical providers to treat patients' full abdomen and flanks. Parent company Dominion Aesthetic Technologies describe
- U.S. FDA Clears Renuvion to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://modernaesthetics.com/news/fda-clears-of-renuvion-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2473371/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas
- Meet Radiesse (+) from Merz: The First and Only Aesthetic Injectable for Jawline Contourhttps://modernaesthetics.com/news/meet-radiesse-from-merz-the-first-and-only-aesthetic-injectable-for-jawline-contour/2473190/Merz Aesthetics is launching Radiesse (+) Lidocaine for jawline contouring in adults over the age of 21. Radiesse (+) is the first and only U.S. Food and Drug Administration (FDA)-approved injectable treatment for jawline contour improvement. The FDA approved the supplemental
- ARTAS Training Available: Restoration Robotics Launches Continuing Education Serieshttps://modernaesthetics.com/news/artas-training-available-restoration-robotics-launches-continuing-education-series/2472080/Restoration Robotics, Inc. is launching a continuing education Master Class Series for its ARTAS® Robotic Hair Restoration System to train physicians on best practices and the most up-to-date techniques for the technology. The Master Class Series will enable users to provide exceptional
- InMode Launches Embrace RF Facial Contouring Solutionhttps://modernaesthetics.com/news/inmode-launches-embrace-rf-facial-contouring-solution/2472082/InMode Aesthetic Solutions is introducing EmbraceRF to target the neck and face through a powerful combination of InMode’s proprietary technologies: FaceTite and Morpheus8. InMode says the new facial contouring solution address a tr
- AAD Selects ContextMedia:Health as Patient Education Affinity Partnerhttps://modernaesthetics.com/news/aad-selects-contextmediahealth-as-patient-education-affinity-partner/2472318/ContextMedia:Health is now an Affinity Partner with the American Academy of Dermatology (AAD). The partnership offers ContextMedia:Health's suite of digital technology to the AAD's U.S. members at no cost. The agreement also bring
- Demand for Minimally Invasive Procedures Contributing to Medical Laser Technologies Surgehttps://modernaesthetics.com/news/demand-for-minimally-invasive-procedures-contributing-to-medical-laser-technologies-surge/2473617/The global market for medical laser technologies is forecasted to reach $6.4 billion in 2024, according to research from the Medical Laster Technologies – A Global Market Overview. The report explores the market value from 2020 to 2029. Research found the medical laser techn